A study on 6,681 people using GLP-1s found that sustained GLP-1 use was associated with a 2.5% absolute risk reduction of myocardial infarction, stroke and cardiovascular mortality over 3.5 years
J Clin Endocrinol Metab 86:47894797
The natural history of nonalcoholic steatohepatitis: A followup study of fortytwo patients for up to 21 years
Additionally, Mendelian randomization studies have found that higher circulating glutamine is associated with reduced IPF risk, suggesting a protective role [132]
Complimentary InBody Scans for Continued Progress 3-, 6-, and 12-month check-ins: FREE for all previous weight loss patients Available at our Fayetteville clinic quick, easy, and helps you stay accountable Track fat loss, muscle gain, hydration, and more at no additional cost GLP-1 Microdosing Program $300 Experience the metabolic and cardiovascular benefits of GLP-1 therapy beyond weight loss